Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.12434
Abstract: This secondary analysis of a randomized clinical trial examines whether automated self-association training can prolong the antidepressant effect of a single infusion of ketamine beyond 1 month in patients with treatment-resistant depression. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Psychiatry"
DOI: 10.1001/jamapsychiatry.2022.3860
Abstract: This cohort study examines data for episodes of unipolar major depressive disorder that met criteria for treatment-resistant depression to assess its impact on individuals and society and consider potential prognostic factors. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Brain and Behavior"
DOI: 10.1002/brb3.1654
Abstract: Electroconvulsive therapy (ECT) is an effective treatment for patients with mood disorders and is most often used for treatment‐resistant cases. This study aimed to examine the effectiveness of ECT in a real‐world treatment sample in… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Depression and Anxiety"
DOI: 10.1002/da.22774
Abstract: Treatment for depressive disorders often requires subsequent interventions. Patients who do not respond to antidepressants have treatment‐resistant depression (TRD). Predicting who will develop TRD may help healthcare providers make more effective treatment decisions. We sought… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Depression and Anxiety"
DOI: 10.1002/da.23097
Abstract: There is growing interest in the potential of neuromodulation options in treatment‐resistant obsessive–compulsive disorder (OCD). Magnetic seizure therapy (MST), is a new treatment intervention in which generalized seizures are induced with transcranial magnetic stimulation. We… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Human Brain Mapping"
DOI: 10.1002/hbm.26217
Abstract: Ketamine produces fast‐acting antidepressant effects in treatment resistant depression (TRD). Though prior studies report ketamine‐related changes in brain activity in TRD, understanding of ketamine's effect on white matter (WM) microstructure remains limited. We thus sought… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12100
Abstract: A substantial proportion of major depressive disorder patients are treatment‐resistant to antidepressant therapy, who require augmentation drugs, or other treatments including electroconvulsive therapy or transcranial magnetic stimulation. Identifying treatment‐resistant major depressive disorder patients before the… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12244
Abstract: Supporting patients upon discharge following prolonged hospitalization in private psychiatric hospitals in Japan have long been an issue. This study evaluated the efficacy of clozapine in treating long‐stay patients with treatment‐resistant schizophrenia to reduce the… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.24939
Abstract: Respiratory infections caused by non‐tuberculous mycobacteria (NTM) are a major cause of morbidity for patients living with cystic fibrosis (CF), as NTM pulmonary disease (NTM‐PD) is challenging to both diagnose and eradicate. Despite the lengthy… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Prescriber"
DOI: 10.1002/psb.1845
Abstract: A nasal spray formulation of esketamine (Spravato) was licensed as adjunctive therapy for the management of adults with treatment‐resistant major depression in December. This article discusses the properties, clinical trial efficacy and adverse effects of… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "European Archives of Psychiatry and Clinical Neuroscience"
DOI: 10.1007/s00406-020-01142-x
Abstract: Several reports point to the beneficial effects of repetitive transcranial magnetic stimulation (rTMS) in the treatment of resistant obsessive–compulsive disorder (OCD). This study aimed to evaluate the safety and efficacy of rTMS targeting the dmPFC… read more here.